News from pbl assay science

( NASDAQ-NMS:DISCA,NASDAQ-NMS:DISCB,NASDAQ-NMS:DISCK)

Feb 19, 2014, 12:00 ET

PBL Assay Science broadens offerings with authentic human cell-expressed cytokines and growth factors in licensing agreement with HumanZyme, Inc.

 PBL Assay Science announces a licensing agreement with HumanZyme, Inc. (Chicago, USA) to expand reagent offerings.  The agreement allows...

Nov 19, 2013, 11:00 ET

PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma

 PBL Assay Science announces the expansion of its assay services portfolio to include 38 different ultra-sensitive biomolecule assays using the...

Sep 18, 2013, 09:33 ET
PBL Assay Science.  (PRNewsFoto/PBL Assay Science)

PBL InterferonSource Changes Name To PBL Assay Science Reflecting Broader Offerings.

PBL InterferonSource, a major provider of products, services, information, and know-how related to interferons, cytokines, antibodies,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge